Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
-
Jana Milerová
Abstract
Thyroid hormones and thyroid autoantibodies, along with serum concentrations of two phytoestrogens of the isoflavone series, daidzein and genistein, were measured in 268 children without overt thyroid diseases, screened for iodine deficiency in one region of the Czech Republic. Since both phytoestrogens have been reported to inhibit thyroid hormone biosynthesis and in high concentrations to exert goitrogenic effects, we investigated whether their presence in the circulation could influence thyroid hormone function in a population where soy consumption is not common. Correlation analysis revealed a significant positive association of genistein with thyroglobulin autoantibodies and a negative correlation with thyroid volume. Multiple regression analysis of the relationships between actual phytoestrogen levels and measured thyroid parameters revealed only a weak but significant association between genistein and thyroid variables. Higher levels of free thyroxine were found in a subgroup of 36 children who ate soy food in the previous 24h. In conclusion, only modest association was found between actual phytoestrogen levels and parameters of thyroid function. On the other hand, even small differences in soy phytoestrogen intake may influence thyroid function, which could be important when iodine intake is insufficient.
References
1. Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002; 83:113–8.10.1016/S0960-0760(02)00273-XSearch in Google Scholar
2. Mishra SI, Dickerson V, Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J Obstet Gynecol 2003; 188(Suppl 5):S66–70.10.1067/mob.2003.405Search in Google Scholar
3. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke D. Phytoestrogens for hormone replacement therapy. J Steroid Biochem Mol Biol 2002; 83:133–47.10.1016/S0960-0760(02)00259-5Search in Google Scholar
4. Kurzer MS. Phytoestrogen supplement use by women. J Nutr 2003; 133:1983–6.10.1093/jn/133.6.1983SSearch in Google Scholar
5. Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003; 78(Suppl 3):593S–609S.10.1093/ajcn/78.3.593SSearch in Google Scholar
6. Whitten PL, Patisaul HB. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 2001; 109(Suppl 1):5–20.10.1289/ehp.01109s15Search in Google Scholar
7. Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol 2000; 168:244–52.10.1006/taap.2000.9019Search in Google Scholar
8. Divi RL, Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol 1996; 9:16–23.10.1021/tx950076mSearch in Google Scholar
9. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization and mechanism of action. Biochem Pharmacol 1997; 54:1087–96.10.1016/S0006-2952(97)00301-8Search in Google Scholar
10. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect 2002; 110(Suppl 3):349–53.10.1289/ehp.02110s3349Search in Google Scholar PubMed PubMed Central
11. Doerge DR, Chang HC. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J Chromatogr B 2002; 777:269–79.10.1016/S1570-0232(02)00214-3Search in Google Scholar
12. Gutekunst R, Martin-Teichert H. Requirements for goiter surveys and determination of thyroid size. In: Delange F, editor. Iodine deficiency in Europe. A continuing concern. New York: Plenum Press, 1993:109–18.Search in Google Scholar
13. Lapčík O, Hampl R, Al-Maharik N, Salakka A, Wähälä K, Adlercreutz H. A novel radioimmunoassay for daidzein. Steroids 1997; 62:315–20.10.1016/S0039-128X(96)00226-7Search in Google Scholar
14. Lapčík O, Hampl R, Hill M, Al Maharik N, Wähälä K, Adlercreutz H. Radioimmunoassay of free genistein in human serum. J Steroid Biochem Mol Biol 1998; 64:261–8.10.1016/S0960-0760(97)00199-4Search in Google Scholar
15. Wang GJ, Lapcik O, Hampl R, Uehara M, Al-Maharik N, Stumpf K, et al. Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 2000; 65:339–48.10.1016/S0039-128X(00)00089-1Search in Google Scholar
16. Fort P, Moses N, Fasano M, Goodberg T, Lifshitz F. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J Am Coll Nutr 1990; 9:164–7.10.1080/07315724.1990.10720366Search in Google Scholar PubMed
17. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999; 84:192–7.10.1210/jc.84.1.192Search in Google Scholar
18. Watanabe S, Terashima K, Sato Y, Arai S, Eboshida A. Effects of isoflavone supplement in healthy women. Biofactors 2000; 12:233–41.10.1002/biof.5520120136Search in Google Scholar PubMed
19. Duncan AM, Underhill KEW, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999; 84:3479–84.Search in Google Scholar
20. Bruce B, Messina N, Spiller GA. Isoflavone supplements do not affect thyroid function in iodine-replete post-menopausal women. J Med Food 2003; 6:309–16.10.1089/109662003772519859Search in Google Scholar PubMed
21. Ishizuki Y, Hirooka Y, Murata Y, Togashi K. The effect on the thyroid gland of soybeans administered experimentally in healthy subjects. Nippon Naibunpi Gakkai Zasshi 1991; 67:622–9.10.1507/endocrine1927.67.5_622Search in Google Scholar PubMed
22. Zamrazil V. IDD status in Czech Republic. J Endocrinol Invest 2003; 26(Suppl 9):14–5.Search in Google Scholar
23. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43:55–68.10.1111/j.1365-2265.1995.tb01894.xSearch in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
